Tuberculosis can be treated, prevented, and cured. Rapid, sustained declines in tuberculosis
deaths in many countries during the past 50 years provide compelling evidence that …

Background Since its appearance in late 2019, infections caused by severe acute respiratory
syndrome coronavirus 2 have created unprecedented challenges for health systems …

After the first cases of coronavirus disease 2019 (COVID-19) were reported on December 31,
2019, and its causative agent, severe acute respiratory syndrome coronavirus 2 was …

Lung infections can be severe consequences of chemotherapy-induced immune defects.
Aetiological causes of infection include bacteria (most commonly Pseudomonas aeruginosa, …

The first antiretroviral drug to be licensed, zidovudine, became available in 1987. Until
December 1995, the antiretroviral drugs available and approved for clinical use in the United …

… Author links open overlay panel Zelalem Temesgen MD a , Mariam Assi MD a , FNU Shweta
MBBS a , Paschalis Vergidis MD a , Stacey A. Rizza MD a , Philippe R. Bauer MD, PhD b , …

Background The pathophysiology of COVID-19 includes immune-mediated
hyperinflammation, which could potentially lead to respiratory failure and death. Granulocyte-macrophage …

Background Since the 1918 influenza pandemic, non-randomised studies and small clinical
trials have suggested that convalescent plasma or anti-influenza hyperimmune intravenous …

Understanding temporal dynamics of COVID-19 symptoms could provide fine-grained resolution
to guide clinical decision-making. Here, we use deep neural networks over an institution…

Non-tuberculous mycobacteria (NTM) is a collective name given to a group of more than
190 species of Mycobacterium. The clinical presentation for most NTM infections is non-specific, …